Active clinical trials
Exudative/Wet AMD
Trial for the treatment of Wet Age-related Macular Degeneration
- Duration: 2 years
- Impact: International
- Treatment: Intravitreal/Intraocular injections
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Dry / Atrophic AMD
Trial for the treatment of Atrophic Macular Degeneration
- Duration: 18 months
- Impact: International
- Treatment: Gene therapy
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Dry Eye
Study on the treatment of Moderate and Severe Dry Eye related to Keratitis or Keratoconjunctivitis
- Duration: 3 months
- Impact: International
- Treatment: Topical eye formula (drops)
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Neurotrophic Keratopathy
Study on the treatment of Neurotrophic Keratopathy.
- Duration: 6 weeks Impact
- International Treatment: Ophthalmic solution (eye drops)
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Intracorneal Rings
Prospective study to assess the clinical outcome of the Intrastromal Corneal Ring implanted in patients with Keratoconus.
- Duration: 3 years
- Impact: International
- Treatment: Corneal ring implanted using femtosecond laser
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Open recruitment
Intraocular Lenses
Prospective study to assess the clinical outcome of Toric Phakic Intraocular Lens implantation in patients with Moderate/High Myopia with Astigmatism.
- Duration: 3 years
- Impact: International
- Treatment: Implantation of toric phakic intraocular lens
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Study activation scheduled for November/December 2023.
Prospective post-market study to evaluate the performance of Phakic Lens in patients with Myopia.
- Duration: 3 years
- Impact: International
- Treatment: Implantation of phakic intraocular lens
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Study activation scheduled for October/November 2023.
Prospective study to compare outcomes of two Trifocal Toric Lenses in patients with Cataracts and coexisting Astigmatism who wish to be treated for presbyopia.
- Duration: 3 years
- Impact: International
- Treatment: Implantation of trifocal phakic intraocular lens
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Study activation scheduled for November/December 2023.
Enfermedad Ocular Tiroidea
- Fase: 3
- Duración: 1 año
- Impacto: Internacional
- Tratamiento: Anticuerpo Monoclonal Humanizado
- Coste para el paciente: 0 €
- Gastos de desplazamiento: Cubiertos
Activación del estudio prevista para finales de abril de 2024
Atrofias Geográficas
- Duración: 1 año y medio
- Impacto: Internacional
- Estudio Prospectivo no intervencionista
- Coste para el paciente: 0 €
- Gastos de desplazamiento: Cubiertos
Activación del estudio prevista en mayo de 2024
Blefaroespasmo
- Fase 2
- Duración: 9 meses
- Impacto: Internacional
- Tratamiento: serotipo de neurotoxina botulínica recombinante modificado
- Coste para el paciente: 0 €
- Gastos de desplazamiento: Cubiertos
Activación del estudio prevista en septiembre/octubre de 2024
Application form
Please complete the form and select the clinical study that interests you the most. After receiving your application, we will contact you to start the participation process.